ISHLT 37th Annual Meeting & Scientific Sessions (Pharmacist Evaluation)
How would you like your name to appear on your certificate?
Profession
Select Your Profession
Other
Pharmacist
Next
What activities did you attend at the event?
Wednesday, April 5 - 8:00 am - 10:00 am
-- Select an Activity --
Symposium 1: ISHLT-ICCAC Joint Symposium: Besides the Surgery – How to Make VAD Patients Successful - 0453-9999-17-002-L04-P
Symposium 2 When Should We Call It Quits? – The Efficacy of Interventions to Ameliorate Pscychosocial Risk Factors - 0453-9999-17-003-L04-P
Symposium 3 PGD and Vasoplegia After Heart Transplantation – Sink or Swim - 0453-9999-17-004-L04-P
Symposium 4 Thinking Outside the Box: Extra-Pulmonary Management in Lung Transplantation - 0453-9999-17-005-L04-P
Symposium 5 Joint ISHLT/PHA Symposium: PH and Transplant – Where Do We Go From Here? - 0453-9999-17-006-L04-P
Symposium 6 The Failing Fontan – Where Do We Go From Here? - 0453-9999-17-007-L04-P
Symposium 7 Joint ISHLT/ESCMID Symposium: Ongoing Challenges in Transplant Infectious Diseases - 0453-9999-17-008-L04-P
Wednesday, April 5 - 10:30 am - 12:30 pm
-- Select an Activity --
Opening Plenary Session - 0453-9999-17-009-L04-PÂ
Wednesday, April 5 - 4:30 pm - 6:00 pm
-- Select an Activity --
Symposium 9 JHLT at ISHLT: The Year in a Capsule - 0453-9999-17-010-L04-P
Thursday, April 6 - 7:00 am - 8:00 am
-- Select an Activity --
Sunrise Symposium 2 Chagasic Cardiomyopathy: Lessons To Be Learned - 0453-9999-17-011-L04-P
Sunrise Symposium 3 Lifecycle Journey of Thrombosis in Mechanical Circulatory Support Patients - 0453-9999-17-012-L04-P
Sunrise Symposium 4 Completing the Picture: Patient Reported Outcomes (PROs) as an Essential Source of Information in Evaluating Transplantation… - 04
Sunrise Symposium 5 Upcoming Opportunities and Challenges in Pediatric Lung Transplantation - 0453-9999-17-014-L04-P
Sunrise Symposium 6 “Those Darn CARVsâ€: Respiratory Viruses in Lung Transplant - 0453-9999-17-015-L04-P
Thursday, April 6 - 8:00 am - 10:00 am
-- Select an Activity --
Symposium 10 Antibodies in Mechanical Circulatory Support: The Phantom Menace - 0453-9999-17-016-L04-P
Symposium 11 Not CAVing to CLADtastrophy: Emerging Mechanisms of Chronic Heart and Lung Allograft Disease - 0453-9999-17-017-L04-P
Symposium 14 CTEPH: Current Controversies and New Directions - 0453-9999-17-018-L04-P
Symposium 15 HLA, AMR and DSA – Approaching Antibodies in Kids - 0453-9999-17-019-L04-P
Symposium 16 “Around the World in 80 Daysâ€: Infectious Challenges in Cardiothoracic Transplantation - 0453-9999-17-020-L04-P
Thursday, April 6 - 10:30 am - 12:30 pm
-- Select an Activity --
Plenary Session - 0453-9999-17-021-L04-P
Thursday, April 6 - 4:00 pm - 6:00 pm
-- Select an Activity --
Symposium 18 Weeding Out Fact from Fiction: The Highs and Lows of Marijuana Use in Transplant - 0453-9999-17-022-L04-P
Symposium 19 Cardiogenic Shock: Types, Teams and Tactics - 0453-9999-17-023-L04-P
Symposium 20 ECMO in Lung Transplantation: Sensational Success or Fantastic Failure? - 0453-9999-17-024-L04-P
Symposium 22 Let’s Get Personal! Precision Diagnostics in Thoracic Transplantation - 0453-9999-17-025-L04-P
Symposium 23 Taming of the Shrew: Mycobacterium Abscessus in Lung Transplantation - 0453-9999-17-026-L04-P
Friday, April 7 - 7:00 am - 8:00 am
-- Select an Activity --
Sunrise Symposium 8 Live Long and Prosper: Thriving After Pediatric Transplantation - 0453-9999-17-027-L04-P
Sunrise Symposium 9 Mixed Rejection (MR) of the Cardiac Allograft: The Next Frontier - 0453-9999-17-028-L04-P
Sunrise Symposium 10 Contrasts and Similarities in Children and Adults: IPAH, Portopulmonary Hypertension, and Perioperative Management - 0453-9999-17
Sunrise Symposium 12 HIV and Transplantation: It Isn’t Going Away - 0453-9999-17-030-L04-P
Friday, April 7 - 1:30 pm - 3:30 pm
-- Select an Activity --
Symposium 24 Aiming Off Target: Non-Cardiac Consequences of LVAD Support - 0453-9999-17-031-L04-P
Symposium 25 Dealing with Antibodies Before and After Heart Transplant: Do We Have New Arrows in our Quiver? - 0453-9999-17-032-L04-P
Symposium 27 Bench to Bedside: How Advances in Immunology Shape the Care of Today’s Lung Transplant Recipients - 0453-9999-17-033-L04-P
Symposium 28 Great Debates in Pulmonary Hypertension - 0453-9999-17-034-L04-P
Symposium 30 E-health, Wearables, Social Media and Big Data in Transplantation: Fancy Toys or True Care Innovations? - 0453-9999-17-035-L04-P
Saturday, April 8 - 7:00 am - 8:00 am
-- Select an Activity --
Sunrise Symposium 15 Extracorporeal Photopheresis: Shedding Light on Rejection - 0453-9999-17-036-L04-P
Sunrise Symposium 16 Pregnant: Scared? So Are We…Management of Pregnancy in Our Complex Patients - 0453-9999-17-037-L04-P
Sunrise Symposium 17 Living in a ‘Bacterial’ World: Microblome in Thoracic Transplantation - 0453-9999-17-038-L04-P
Saturday, April 8 - 9:45 am - 11:45 am
-- Select an Activity --
Plenary Session - 0453-9999-17-039-L04-P
Previous
Next
Agreement
By completing this form, you attest that you have participated in all selected activities in thier entirety.
I agree
Previous
Next
PHARMACISTS ONLY -- Please provide the following:
NABP eProfile ID (ePID):
Date of Birth (MM/DD) - Example September 24 would be 0924:
How well are you able to meet the following objective? Evaluate the need for antiplatelet drugs and anticoagulants in LVAD patients.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Explain how social support and psychiatric risk impact transplant and MCS recipients.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Identify risk factors for primary graft dysfunction after heart transplantation.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Describe extra-pulmonary issues impacting the post-transplant care of thoracic transplant recipients.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Assist with the IV - PO conversion of prostanoid therapies for pulmonary hypertension patients.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Describe the challenges of managing Fontan patients undergoing heart transplant.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Discuss relevant issues in the management of transplant and MCS patients with infections.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Explain current trends in both thoracic transplant recipients and MCS patients.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Describe and discuss key articles published in the
Journal of Heart and Lung Transplantation
during 2016.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Formulate a pharmacotherapy regimen to treat Chagas disease post-transplant.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Provide pharmacotherapy recommendations to prevent thrombosis in MCS patients.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Explain Patient Reported Outcomes Research and describe how it may be applied to pharmaceutical care.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Discuss ABO-incompatible pediatric lung transplant as a means of expanding the donor pool.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Evaluate the current evidence for and against the treatment of community acquired respiratory infections after lung transplantation.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Formulate a strategy for desensitization of patients prior to heart transplant.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Explain the role of antibodies in chronic graft dysfunction after heart and lung transplantation.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Discuss current best practices in the management of chronic thromboembolic pulmonary hypertension patients.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Formulate a treatment plan for antibody mediated rejection after pediatric heart and lung transplanation.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Provide recommendations for the prophylaxis of infections related to travel in transplant recipients.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Discuss current options regarding the use of social media communications in medicine.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Discuss the pros and cons of relaxed marijuana laws as related to transplant patients.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Describe the use of temporary mechanical circulatory support in the management of cardiogenic shock.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Discuss the use of ECMO in lung transplantation.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Discuss precision diagnostic testing that may be on the horizon for use in heart and lung transplant recipients.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Recommend pharmacotherapy for the treatment of mycobacterium abcessus infections in lung transplant recipients.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Explain communication strategies that are more likely to help clinicians connect with adolescent transplant paitnets.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Discuss mixed rejection as a new phenotype of rejection after heart transplantation.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Discuss the management of pulmonary hypertension in pediatric patients.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Provide pharmacotherapy recommendations for the management of transplant recipients with HIV.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Discuss the effect of LVADs on other organ systems in LVAD patients.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Evaluate the pros and cons of treating asymptomatic heart transplant recipients with DSAs post-transplant.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Describe novel biological and antibody-targeted therapies in lung transplantation.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Discuss current controversies in the treatment of PAH patients.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Explain the current state of e-health technologies and their application to the care of transplant recipients.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Describe the use of extracorporeal photopheresis in heart and lung transplant recipients.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Recommend safe pharmacotherapy for transplant and MCS patients during and after pregnancy.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Discuss the role of the microbiome and its impact on outcomes after heart and lung transplantation.
Excellent
Very Good
Good
Fair
Poor
How well are you able to meet the following objective? Describe the relationship between financial markets and the funding of early-stage drug development.
Excellent
Very Good
Good
Fair
Poor
Previous
Next
Was the educational content of value to you?
Yes
No
Previous
Next
If no, please exlain...
Previous
Next
Was the educational content scientifically sound?
Yes
No
Previous
Next
If yes, what...
Previous
Next
Did you perceive any commercial bias or influence in the educational content?
Yes
No
Previous
Next
If yes, how...
Previous
Next
Did this activity improve your competence, or performance?
Yes
No
Previous
Next
Tell us how well or poorly we met any of the educational objectives
Previous
Next
What did you learn that will help you in your practice?
Previous
Next
Tell us what was good or bad about any part of the educational activity, content, speakers, materials, anything
Previous
Next
What questions are you having in your practice that you would like to see addressed in an educational activity?
Previous
